HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

EHC

Encompass Health Corporation (NYSE)

Healthcare — Medical Care Facilities

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Strong Buy 1.1 / 5 12 analysts
$101.39
+$0.31 (+0.31%)
Target: $140.50 (38.6%)
Sign in to add EHC to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$10.06B
P/E Ratio (TTM)17.36
Forward P/E15.51
EPS (TTM)$5.84
Dividend Yield0.75%
Profit Margin10.04%
Revenue Growth9.00%
ROE25.23%
Debt/Equity82.84
Recommendation Strong Buy 1.1
Analyst Target$140.50
Analysts12
Indexes NYSE

Technical Indicators

RSI (14)43.8
Beta0.60
SMA 20-
SMA 40-
52-Week High$127.99
52-Week Low$92.77
50-Day Avg$103.13
200-Day Avg$108.51
Avg Volume$1.02M
Volume558.4K

Performance Analysis

NEUTRAL

EHC presents a mixed picture with both positive and negative indicators.

~ Trading at 24% of its 52-week range.
~ RSI at 43.8 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 9.0% year-over-year.
+ Wall Street consensus is "Strong Buy" from 12 analysts.
+ Average analyst target of $140.50 implies 38.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:07 UTC

Back to Screener Export Report